Very early researchUnknownNCT06098898What this trial is testingSafety and Efficacy of NK510 to Treat Gastric CancerWho this might be right forGastric Cancer Base Therapeutics (Shanghai) Co., Ltd. 9
Testing effectiveness (Phase 2)Looking for participantsNCT04592211What this trial is testingPembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) CancerWho this might be right forGastric Cancer Stage IV Yonsei University 71
Not applicableLooking for participantsNCT04740346What this trial is testingSurvival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)Who this might be right forGastric CancerRecurrenceQuality of Life National Cancer Center, Korea 886
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT05535569What this trial is testingPhase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric CancerWho this might be right forRecurrent/Metastatic Gastric Cancer Yonsei University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04847466What this trial is testingImmunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck CancerWho this might be right forGastroesophageal Junction (GEJ) CancersAdvanced HNSCC National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)UnknownNCT04739202What this trial is testingPersonalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST)Who this might be right forGastric AdenocarcinomaMetastatic Gastric CancerMetastatic Adenocarcinoma+1 more Hospices Civils de Lyon 60
Early research (Phase 1)Study completedNCT00486356What this trial is testingCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more University of Nebraska 46
Early research (Phase 1)Ended earlyNCT01212887What this trial is testingTreated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With CancerWho this might be right forBreast CancerColorectal CancerGastric Cancer+4 more Cancer Research UK 14
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00313599What this trial is testingLapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more University of California, San Francisco 28
Testing effectiveness (Phase 2)UnknownNCT01180166What this trial is testingCombination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric CancerWho this might be right forGastric CancerConcurrent Chemoradiotherapy Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)UnknownNCT01100801What this trial is testingGenomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer PatientsWho this might be right forRecurrent Gastric Cancer National University Hospital, Singapore 90
Early research (Phase 1)Study completedNCT04074343What this trial is testingTAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroEsophageal Cancer University of California, Irvine 20
Testing effectiveness (Phase 2)Study completedNCT00004235What this trial is testingDocetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or StomachWho this might be right forEsophageal CancerGastric Cancer Alliance for Clinical Trials in Oncology 47
Early research (Phase 1)Study completedNCT00005860What this trial is testingOxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT03175224What this trial is testingAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsWho this might be right forSolid TumorsAdvanced CancerRenal Cancer+15 more Apollomics Inc. 497
Large-scale testing (Phase 3)UnknownNCT02773524What this trial is testingRegorafenib in Refractory Advanced Gastro-Oesophageal CancerWho this might be right forGastro-Oesophageal Cancer Australasian Gastro-Intestinal Trials Group 250
Large-scale testing (Phase 3)Study completedNCT02746796What this trial is testingStudy of ONO-4538 in Gastric CancerWho this might be right forGastric Cancer Ono Pharmaceutical Co. Ltd 680